WVE

Wave Life Sciences Ltd.

Price

$4.67

return (12m)

-41.63%

p/e

-5.10

p/bv

2.28

DIVIDEND YIELD

0.00%

WVE price

Wave Life Sciences

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment WVE

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

-21.37%

3 months

-18.50%

1 year

-41.63%

2 years

-15.86%

5 years

-25.04%

10 years

0.00%

Asset Comparator

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Fundamentals WVE

Valuation

P/E

-5.10

Sector -0.30

Industry -3.74

P/BV

2.28

Sector 1.88

Industry 1.32

P/Revenue (PSR)

15.80

Sector 1.62

Industry 2.27

EV/EBITDA

Sector -56.73

Industry -38.51

EV/EBIT

Sector -495.32

Industry -61.92

P/EBITDA

Sector -192.31

Industry -39.83

P/EBIT

Sector -230.06

Industry -59.07

P/Total Assets

1.85

Sector 0.90

Industry 0.86

P/Net Current Assets

2.57

Sector -24.09

Industry -82.44

P/Working Capital

2.26

Sector -5.12

Industry -6.69

EPS

-0.99

Sector -0.78

Industry -1.25

BVPS

2.22

Sector 3.80

Industry 2.23

Efficiency

Gross Margin

100.00%

Sector 48.34%

Industry 49.22%

EBITDA Margin

0.00%

Sector -5,407,515.68%

Industry -20,100,387.98%

EBIT Margin

0.00%

Sector -62.93%

Industry -18,749,058.89%

Operating Margin

-100.00%

Sector -22.73%

Industry -30.01%

Net Profit Margins

-100.00%

Sector -27.03%

Industry -32.63%

Asset Turnover

0.00

Sector 0.13

Industry 0.06

Profitability

ROE

-44.65%

Sector -30.72%

Industry -44.11%

ROA

-36.27%

Sector -28.03%

Industry -50.97%

ROIC

0.00%

Sector -317.33%

Industry -162.60%

Dividends

Dividend yield

0.00%

Sector -

Industry -

Payout

Sector -

Industry -

Debt

Current Ratio

9.99

Sector 1.85

Industry 2.38

Net Debt / EBITDA

Sector -42.45

Industry -15.77

Net Debt / EBIT

Sector -37.26

Industry -71.89

Net Debt / Equity

0.00

Sector -1.04

Industry -1.11

Gross Debt / Equity

0.00

Sector -0.72

Industry -0.54

Equity/Assets

0.81

Sector 0.44

Industry 0.49

Liabilities/Assets

0.19

Sector 0.48

Industry 0.44

Growth

5Y Revenue CAGR

10.77%

Sector -

Industry -

5Y Earnings CAGR

10.62%

Sector -

Industry -

Fundamentals WVE

DRAG THE FRAME TO SEE MORE DATA

Assets	Price (US$)	Return 12m	DY	P/E	P/BV	ROE	Net Profit Margins
WVE Wave Life Sciences Ltd.	$4.67	-51.46%	0.00%	-5.10	2.28	-44.65%	-100.00%
LLY Eli Lilly and Compay	$1,154.74	57.84%	0.55%	39.01	-	-%	33.53%
SNY Sanofi	$44.30	-7.12%	3.94%	7.29	1.34	18.43%	13.81%
GSK GlaxoSmithKline PLC	$50.64	35.95%	3.52%	15.45	4.36	28.24%	14.54%
CRMD CorMedix Inc.	$8.52	-41.80%	0.00%	3.43	1.39	40.62%	40.49%
AMPH Amphastar Pharmaceuticals Inc.	$23.52	-23.66%	0.00%	12.19	1.25	10.23%	10.76%
RDY Dr. Reddy's Laboratories Ltd.	$11.98	-14.58%	0.69%	27.49	2.48	9.03%	10.14%
ISRG Intuitive Surgical Inc.	$368.37	-21.47%	0.00%	41.68	7.19	17.26%	28.62%
NVS Novartis AG	$162.77	31.03%	2.03%	27.32	7.50	27.47%	26.57%
TMO Thermo Fisher Scientific Inc.	$610.63	25.79%	0.29%	32.83	4.35	13.26%	15.08%
ABT Abbott Laboratories	$108.56	-15.99%	2.25%	35.46	3.76	10.61%	11.65%
MDT Medtronic PLC	$92.44	3.06%	3.15%	24.14	2.31	9.59%	13.20%
BSX Boston Scientific Corp.	$47.00	-55.93%	0.00%	16.90	0.00	-%	19.57%
TMDX TransMedics Group Inc.	$86.32	-22.62%	0.00%	21.17	6.20	29.28%	22.69%
IDXX IDEXX Laboratories Inc.	$530.26	-17.08%	0.00%	38.35	27.10	70.67%	25.03%
RMD ResMed Inc.	$229.58	-14.20%	1.01%	22.70	5.31	23.41%	27.44%
DHR Danaher Corporation	$208.55	5.34%	0.67%	37.93	2.89	7.61%	15.95%
HCA HCA Healthcare Inc.	$409.57	1.51%	0.72%	11.79	-28.86	-244.72%	10.07%
COHR Coherent Inc.	$267.30	204.44%	0.00%	118.60	4.87	4.11%	6.85%
SYK Stryker Corp.	$309.96	-19.49%	1.07%	33.63	5.23	15.55%	14.43%
PHG Koninklijke Philips NV	$25.99	-0.19%	3.79%	19.71	1.93	9.80%	6.30%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

WVE Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT Wave Life Sciences

Wave Life Sciences Ltd.

Average Investor10 user rating

4.0 (2 people)

United States

14 years

Founded: 2012

2015

Time since IPO - 11 years

220

Employees

Wave Life Sciences Ltd. (United States) is listed on the Nasdaq and has a market capitalization of $1.03 billion, with shareholders equity totaling $453.52 million.

The company employs approximately 220 people and operates in the Health sector, within the Pharmaceutical Products industry.

Over the past 12 months, Wave Life Sciences Ltd. reported $65.38 million in revenue, generating net income of $-202.48 million.

Key financial metrics include a P/E ratio of -5.10, a price-to-book (P/B) ratio of 2.28, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker WVE.

Market cap

$1.03 billion

Net worth

$453.52 million

$453,520,000.00

Assets

$558.32 million

$558,320,000.00

Total Shares Outstanding

204.00 million

204,000,000

Average Daily Trading Volume

$3.00 million

$3,004,096.20

Sector

Health

Industry

Pharmaceutical Products

WVE

WVE revenue and profits

Financial Results WVE

DRAG THE FRAME TO SEE MORE DATA

WVE cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

CVS - CVS Health

$97.84 37,65% (12M)

P/E

-0.84

2.84%

ROE

-178.93%

P/BV

1.50

CI - Cigna

$284.92 --2,55% (12M)

P/E

10.72

2.21%

ROE

16.04%

P/BV

1.72

CNC - Centene

$68.28 127,15% (12M)

P/E

-6.23

0.00%

ROE

-22.56%

P/BV

1.40

HUM - Humana

$412.33 34,08% (12M)

P/E

36.19

0.91%

ROE

6.72%

P/BV

2.43

SNY - Sanofi

$44.30 --7,70% (12M)

P/E

7.29

3.94%

ROE

18.43%

P/BV

1.34

LLY - Eli Lilly

$1,154.74 60,15% (12M)

P/E

39.01

0.55%

ROE

P/BV

HCA - HCA Healthcare

$409.57 1,14% (12M)

P/E

11.79

0.72%

ROE

-244.72%

P/BV

-28.86

NVS - Novartis

$162.77 29,40% (12M)

P/E

27.32

2.03%

ROE

27.47%

P/BV

7.50